Nectar Lifesciences Quarterly Results for Trading Insights
NECLIFE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-176 Cr
QSept 2025
Nectar Lifesciences Quarterly Results Key Highlights
- Revenue of ₹5 Cr in Sept 2025 (-98.8% vs Mar 2025, -58.3% vs Sept 2024)
- Net Profit of ₹-176 Cr in Sept 2025 (-35.4% vs Mar 2025, -3033.3% vs Sept 2024)
- EBITDA of ₹-177 Cr in Sept 2025 (-13.5% vs Mar 2025)
- Operating Margin of -3534.0% in Sept 2025 (-3498.0pp vs Mar 2025)
- Earnings Per Share of ₹-7.84 in Sept 2025 (-35.2% vs Mar 2025)
Nectar Lifesciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 5 | 429 | 6 | 12 | 441 | -98.8% | -58.3% |
| Net Profit (₹ Cr) | -176 | -130 | -63 | 6 | 1 | - | - |
| EBITDA (₹ Cr) | -177 | -156 | -63 | 6 | 49 | - | - |
| EPS (₹) | -7.84 | -5.80 | -2.82 | 0.25 | 0.03 | - | - |
| Operating Margin (%) | -3534.0% | -36.0% | -1212.0% | -10.0% | 11.0% | - | - |
Nectar Lifesciences Share Price Trend Around Quarterly Results
Visualize Nectar Lifesciences's 1-year price movement across quarterly results — ideal for logging trades in Nectar Lifesciences share price
chart using Tickjournal. All values in ₹.
Related Pages for Nectar Lifesciences
Additional stock information and data for NECLIFE
Revenue Trend (₹ Cr)
Sept 2024
12
Jun 2025
6
Mar 2025
429
Sept 2025
5
Net Profit Trend (₹ Cr)
Sept 2024
6
Jun 2025
-63
Mar 2025
-130
Sept 2025
-176
Operating Margin Trend (%)
Sept 2024
-10.0%
Jun 2025
-1212.0%
Mar 2025
-36.0%
Sept 2025
-3534.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Nectar Lifesciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores